Tenatoprazole is a novel proton pump inhibitor indicated for the treatment of reflux oesophagitis and peptic ulcer in Japan. Discovered by Mitsubishi Pharma, it is an imidazopyridine derivative and has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors. It is activated more slowly than other proton pump inhibitors but its inhibition is resistant to reversal.

PropertyValue
dbpedia-owl:Drug/atcPrefix
  • none
dbpedia-owl:Drug/casNumber
  • 113712-98-4
dbpedia-owl:Drug/iupacName
  • 3-Methoxy-8-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-2,7,9-triazabicyclo[4.3.0]nona-2,4,8,10-tetraene
dbpedia-owl:Drug/pubchem
  • 636411
dbpedia-owl:atcPrefix
  • none
dbpedia-owl:casNumber
  • 113712-98-4
dbpedia-owl:iupacName
  • 3-Methoxy-8-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-2,7,9-triazabicyclo[4.3.0]nona-2,4,8,10-tetraene
dbpedia-owl:pubchem
  • 636411
dbpedia-owl:thumbnail
dbpprop:abstract
  • Tenatoprazole is a novel proton pump inhibitor indicated for the treatment of reflux oesophagitis and peptic ulcer in Japan. Discovered by Mitsubishi Pharma, it is an imidazopyridine derivative and has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors. It is activated more slowly than other proton pump inhibitors but its inhibition is resistant to reversal. Tenatoprazole has an extended plasma half-life in comparison with all other proton pump inhibitors; this makes it more potent and effective in the treatment of nocturnal acid breakthrough than esomeprazole, one of the most popular proton pump inhibitors.
  • Tenatoprazol (benatoprazol), proton pompası inhibitörleri grubundan bir antiülser ilaçtır. Molekül bir japon firması tarafından bulunmuştur ancak halihazırda ticari olarak kullanımı mevcut değildir.
dbpprop:atcPrefix
  • none
dbpprop:c
  • 16 (xsd:integer)
dbpprop:casNumber
  • 113712-98-4
dbpprop:eliminationHalfLife
  • 4.8 to 7.7 hours
dbpprop:h
  • 18 (xsd:integer)
dbpprop:hasPhotoCollection
dbpprop:iupacName
  • 3-Methoxy-8-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-2,7,9-triazabicyclo[4.3.0]nona-2,4,8,10-tetraene
dbpprop:metabolism
dbpprop:molecularWeight
  • 346.405 g/mol
dbpprop:n
  • 4 (xsd:integer)
dbpprop:o
  • 3 (xsd:integer)
dbpprop:pubchem
  • 636411 (xsd:integer)
dbpprop:routesOfAdministration
  • Oral
dbpprop:s
  • 1 (xsd:integer)
dbpprop:width
  • 254 (xsd:integer)
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • Tenatoprazole is a novel proton pump inhibitor indicated for the treatment of reflux oesophagitis and peptic ulcer in Japan. Discovered by Mitsubishi Pharma, it is an imidazopyridine derivative and has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors. It is activated more slowly than other proton pump inhibitors but its inhibition is resistant to reversal.
  • Tenatoprazol (benatoprazol), proton pompası inhibitörleri grubundan bir antiülser ilaçtır. Molekül bir japon firması tarafından bulunmuştur ancak halihazırda ticari olarak kullanımı mevcut değildir.
rdfs:label
  • Tenatoprazole
  • Tenatoprazol
owl:sameAs
skos:subject
foaf:depiction
foaf:page
is dbpprop:redirect of
is owl:sameAs of